
Dr. Chandragouda Dodagoudar
Senior Director & Unit Head — Medical Oncology
Medical Oncologist
220 verified reviews
220
Recent Consultations
About Dr. Chandragouda Dodagoudar
Dr. Chandragouda Dodagoudar is a Senior Director and Unit Head of Medical Oncology at BLK-Max Super Speciality Hospital in New Delhi, bringing over 22 years of clinical expertise in comprehensive cancer care. His credentials include MBBS, MD in Medicine, DNB in Medical Oncology, and ECMO qualification from Europe, positioning him as a deeply trained specialist in systemic cancer treatment.
Dr. Dodagoudar has developed particular depth across a wide spectrum of oncological conditions—including head and neck cancer, breast cancer, lung cancer, thoracic cancer, thyroid cancer, gastrointestinal malignancies, gynaecologic cancers, urological cancers, sarcomas, bone cancers, and lymphomas. He is especially skilled in adjuvant and neoadjuvant chemotherapy, palliative chemotherapy, immunotherapy with immune checkpoint inhibitors, hormone therapy for breast and gynaecologic cancers, and molecular targeted therapy guided by biomarker analysis. His evidence-based approach combines cutting-edge systemic therapies with individualised treatment planning.
International patients from the Gulf countries, Africa, and across South Asia regularly seek his care, drawn by his patient-centric philosophy and transparent communication. He works closely with Gaf Healthcare to facilitate seamless consultations via video conferencing, document review, and coordinated care pathways for medical tourists. His fluency in English and Hindi helps him connect with diverse patient populations and explain complex treatment options clearly.
BLK-Max Super Speciality Hospital, where Dr. Dodagoudar leads the oncology unit, is one of India's premier multi-specialty centres with NABH accreditation, advanced diagnostic imaging, dedicated chemotherapy infusion centres, and robust supportive care infrastructure. The hospital has established international patient services, airport liaison, accommodation coordination, and experienced nursing staff trained in international protocols. For international patients, this combination of Dr. Dodagoudar's expertise and BLK-Max's infrastructure ensures comprehensive, safe, and cost-effective cancer treatment in a world-class setting. Patients from overseas benefit from competitive treatment costs, direct access to a senior oncologist, and the ability to continue follow-up care through telemedicine with Gaf Healthcare support.
Conditions Treated by Dr. Chandragouda Dodagoudar
- Head and Neck Cancers
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancers
- Gynaecologic Cancers
- Urological Cancers
- Lymphomas
- Bone and Soft Tissue Sarcomas
- Thyroid Cancer
- Advanced Metastatic Cancer
Areas of Interest
- Adjuvant Chemotherapy
- Neoadjuvant Chemotherapy
- Chemotherapy for Solid Tumors
- Palliative Chemotherapy
- Immunotherapy for Advanced Cancer
- Immune Checkpoint Inhibitor Therapy
- Hormone Therapy for Breast Cancer
- Hormonal Therapy for Gynecologic Cancers
- Molecular Targeted Therapy
- Biomarker-Based Targeted Therapy
- Head & Neck Cancer Treatment
- Lung Cancer Management
Qualifications
- MBBS —
- MD (Medicine) —
- DNB (Medical Oncology) —
- ECMO — Europe
Work Experience
- Senior Director & Unit Head, Medical Oncology, BLK-Max Super Speciality Hospital, New Delhi — Present
- Consultant, Rajiv Gandhi Cancer Hospital, New Delhi
- Senior Resident, Max Healthcare, New Delhi
- Senior Resident, Apollo Hospitals, Bangalore
Certifications (4)
MBBS
MD (Medicine)
DNB (Medical Oncology)
ECMO (European Certification in Medical Oncology)
Europe
Memberships (2)
- Delhi Medical Council
- Karnataka Medical Council
Research Papers & Publications (4)
Immunotherapy and Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Real-World Outcomes
Indian Journal of Medical Oncology — 2022
Neoadjuvant Chemotherapy Followed by Surgery in Locally Advanced Gastric Cancer: Prognostic Factors and Survival Analysis
Journal of Cancer Research and Therapeutics — 2021
Hormone Receptor Status and Molecular Subtyping in Breast Cancer: Implications for Treatment Selection
Indian Journal of Surgical Oncology — 2020
Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma: Clinical Experience and Outcomes
Cancer Medicine India — 2021
Procedures
Frequently Asked Questions
International patients can book a consultation through Gaf Healthcare by submitting their medical reports and history via email or WhatsApp. Dr. Dodagoudar offers video consultations, allowing patients to discuss their condition, obtain a second opinion, and plan treatment without leaving home. Once a diagnosis is confirmed, Gaf Healthcare arranges the complete medical tourism package, including hospital admission, treatment scheduling, and post-operative follow-up. Consultation fees are USD 80, with all details coordinated through our international patient services team.
